Banque Cantonale Vaudoise’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Hold
1
– – ﹤0.01% 883
2026
Q2
$1K Hold
1
– – ﹤0.01% 440
2026
Q1
$0 Hold
1
– – ﹤0.01% 905
2025
Q4
$0 Hold
1
– – ﹤0.01% 846
2025
Q3
$0 Hold
1
– – ﹤0.01% 837
2025
Q2
$1K Hold
1
– – ﹤0.01% 784
2025
Q1
$0 Buy
+1
New +$33 ﹤0.01% 831
2024
Q3
$0 Buy
+1
New +$51 ﹤0.01% 880
2022
Q3
– Hold
0
– – – 1256
2022
Q2
– Hold
0
– – – 1313
2022
Q1
– Hold
0
– – – 1349
2021
Q4
– Hold
0
– – – 1361
2021
Q3
– Hold
0
– – – 1326
2021
Q2
– Hold
0
– – – 1254
2021
Q1
– Hold
0
– – – 1165
2020
Q4
– Hold
0
– – – 1091

Other funds holding MTRI

Banque Cantonale Vaudoise's MTRI Position: Q3 2026 in Review

Banque Cantonale Vaudoise held its Mentari Therapeutics, Inc. Common Stock (MTRI) position steady in Q3 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #883.

Banque Cantonale Vaudoise first reported a position in MTRI in Q3 2024 and has held it in 8 quarters since. The position peaked at $1K in Q2 2026. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.

  • Banque Cantonale Vaudoise held 1 share of Mentari Therapeutics, Inc. Common Stock worth $0 as of Q3 2026.
  • Banque Cantonale Vaudoise left its Mentari Therapeutics, Inc. Common Stock share count unchanged in Q3 2026.
  • Mentari Therapeutics, Inc. Common Stock made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q3 2026, its #883 holding.
  • Banque Cantonale Vaudoise first reported a position in Mentari Therapeutics, Inc. Common Stock in Q3 2024 and has held it in 8 quarters since.
  • Banque Cantonale Vaudoise's Mentari Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2026.
  • 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2026, filed 12 Nov 2026.